David P. Roe sold Remedent Inc (PINK: REMI)
David P. Roe (R-TN), a U.S. Representative, has disclosed 1 trade in Remedent Inc (REMI) since 2020, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: David P. Roe sold $1,000 - $15,000 of Remedent Inc (PINK: REMI) on March 19, 2020. Since that trade, REMI is down -99.56% against the S&P 500 up +237.46%, an outperformance of -337.02%.
Data updated
David P. Roe's REMI trades vs the price
REMI is down -99.56% since David P. Roe sold on March 19, 2020, versus +237.46% for the S&P 500.
Performance since this trade
All David P. Roe REMI trades
David P. Roe & REMI trading FAQ
Is it legal for David P. Roe to trade Remedent Inc (REMI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Remedent Inc (REMI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did David P. Roe sell REMI?
David P. Roe disclosed a sale of $1,000 - $15,000 of Remedent Inc (REMI) on March 19, 2020, according to public STOCK Act filings.
How has REMI performed since David P. Roe's trade?
Since David P. Roe sold REMI on March 19, 2020, the stock is down -99.56%, versus +237.46% for the S&P 500 over the same period, an outperformance of -337.02%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional REMI trades?
Quantellect tracks every disclosed congressional trade in Remedent Inc (REMI) on the Remedent Inc congressional trading page, which aggregates filings across all members of Congress.
David P. Roe's REMI tradesAll congressional filings for Remedent IncDavid P. Roe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.